Nature Clinical Practice Neurology (2007) 3: 120–121 [doi:10.1038/ncpneuro0429]

Corrigendum

In the March 2007 issue, in the Viewpoint article by Bayry et al., page 121, the sentence “FcγRI, FcγRIIa, FcγRIIIa and FcγRIV are activating receptors, whereas FcγRIIb and FcγRIIIb are inhibitory receptors” should have read “FcγRI, FcγRIIa, FcγRIIIa, FcγRIIIb and FcγRIV are activating receptors, whereas FcγRIIb is an inhibitory receptor”.